May 28, 2025 10:55 AM EDT

Insurance startup Devoted Health cuts 5% of workers in small layoff

Shelby Livingston

Health tech correspondent

Devoted Health, the Medicare Advantage insurer with a medical group, has laid off about 120 employees, a company spokesperson confirmed to Endpoints News. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Insurance startup Devoted Health cuts 5% of workers in small layoff

Shelby Livingston

Health tech correspondent

Sign up to read this article for free.

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

Large pharma companies spell out reasons why tariffs will harm US investments

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

Intellia reports case of liver toxicity in ATTR gene editing study

From weeks to days: how Aizon Intelligent Agents transform pharma validation

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

Shelby Livingston

Health tech correspondent

Sign up to read this article for free.

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments

Supreme Court to keep mulling state PBM dis­pute as US urges jus­tices to de­cline case

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

In­tel­lia re­ports case of liv­er tox­i­c­i­ty in AT­TR gene edit­ing study

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

Insurance startup Devoted Health cuts 5% of workers in small layoff

Merck, Daiichi Sankyo scrap FDA application for HER3 ADC after survival miss

Large pharma companies spell out reasons why tariffs will harm US investments

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

Intellia reports case of liver toxicity in ATTR gene editing study

From weeks to days: how Aizon Intelligent Agents transform pharma validation